Locations:

Tag: amyloidosis

November 2, 2020/Cancer/Research

Combination Therapy Shows Promising Results for Treatment of Systemic Light-Chain Amyloidosis

Primary results from the phase 3 ANDROMEDA study

February 26, 2019/Cancer/Research

Antibody Treatment Holds Promise for Patients with Relapsed or Refractory Light-Chain Amyloidosis

Daratumumab is effective and safe

January 15, 2019/Cancer/Research

New Chemotherapy Regimen Proves Effective in Treating Amyloidosis

Refractory patients respond to combination therapy

October 16, 2018/Heart, Vascular and Thoracic/News & Insights

Major Advances Are Afoot in Management of ATTR Cardiac Amyloidosis

New drugs, diagnostic tools are starting to revolutionize care

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

April 16, 2014/Cancer/Innovations

New agents in Multiple Myeloma and Amyloidosis

Comprehensive treatment and trial access show promise

BackPage 1 of 1Next